EASY BIOInc

KQ:353810 Korea Food & Tobacco
Market Cap
$46.52K
₩68.11 Million KRW
Market Cap Rank
#18862 Global
#721 in Korea
Share Price
₩7030.00
Change (1 day)
-0.42%
52-Week Range
₩4660.00 - ₩7940.00
All Time High
₩9790.43
About

EASY BIO,Inc. provides specialized piglet feed and feed additives solutions in South Korea and internationally. The company was founded in 2020 and is based in Seoul, South Korea.

EASY BIOInc (353810) - Net Assets

Latest net assets as of September 2025: ₩100.16 Billion KRW

Based on the latest financial reports, EASY BIOInc (353810) has net assets worth ₩100.16 Billion KRW as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩325.64 Billion) and total liabilities (₩225.48 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩100.16 Billion
% of Total Assets 30.76%
Annual Growth Rate 27.09%
5-Year Change N/A
10-Year Change N/A
Growth Volatility 6.96

EASY BIOInc - Net Assets Trend (2020–2024)

This chart illustrates how EASY BIOInc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for EASY BIOInc (2020–2024)

The table below shows the annual net assets of EASY BIOInc from 2020 to 2024.

Year Net Assets Change
2024-12-31 ₩88.80 Billion +34.19%
2023-12-31 ₩66.17 Billion +32.44%
2022-12-31 ₩49.96 Billion +16.42%
2021-12-31 ₩42.92 Billion +26.08%
2020-12-31 ₩34.04 Billion --

Equity Component Analysis

This analysis shows how different components contribute to EASY BIOInc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 488.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩61.34 Billion 73.05%
Common Stock ₩3.42 Billion 4.07%
Other Components ₩19.21 Billion 22.88%
Total Equity ₩83.97 Billion 100.00%

EASY BIOInc Competitors by Market Cap

The table below lists competitors of EASY BIOInc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in EASY BIOInc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 62,781,956,440 to 83,970,747,170, a change of 21,188,790,730 (33.7%).
  • Net income of 19,604,385,150 contributed positively to equity growth.
  • Dividend payments of 3,413,712,000 reduced retained earnings.
  • Share repurchases of 3,990,803,220 reduced equity.
  • Other factors increased equity by 8,988,920,800.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩19.60 Billion +23.35%
Dividends Paid ₩3.41 Billion -4.07%
Share Repurchases ₩3.99 Billion -4.75%
Other Changes ₩8.99 Billion +10.7%
Total Change ₩- 33.75%

Book Value vs Market Value Analysis

This analysis compares EASY BIOInc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.80x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 7.05x to 2.80x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2020-12-31 ₩997.16 ₩7030.00 x
2021-12-31 ₩1257.23 ₩7030.00 x
2022-12-31 ₩1463.61 ₩7030.00 x
2023-12-31 ₩1839.11 ₩7030.00 x
2024-12-31 ₩2510.55 ₩7030.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently EASY BIOInc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 23.35%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 5.10%
  • • Asset Turnover: 1.07x
  • • Equity Multiplier: 4.29x
  • Recent ROE (23.35%) is below the historical average (24.47%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2020 30.63% 11.83% 0.98x 2.64x ₩7.02 Billion
2021 25.33% 8.40% 1.10x 2.74x ₩6.58 Billion
2022 18.27% 5.87% 0.99x 3.16x ₩4.13 Billion
2023 24.76% 9.40% 0.96x 2.74x ₩9.27 Billion
2024 23.35% 5.10% 1.07x 4.29x ₩11.21 Billion

Industry Comparison

This section compares EASY BIOInc's net assets metrics with peer companies in the Food & Tobacco industry.

Industry Context

  • Industry: Food & Tobacco
  • Average net assets among peers: $101,562,746,244
  • Average return on equity (ROE) among peers: 0.96%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
EASY BIOInc (353810) ₩100.16 Billion 30.63% 2.25x $85.89 Million
MSC Co. Ltd (009780) $28.51 Billion 3.06% 2.50x $22.92 Million
KC Feed Co. Ltd (025880) $48.99 Billion 4.84% 1.25x $23.29 Million
FarmStory Co. Ltd (027710) $148.69 Billion -4.00% 3.43x $53.59 Million
Helixmith Co. Ltd (084990) $142.04 Billion -10.89% 0.05x $126.21 Million
H.Pio Co. Ltd. (357230) $139.59 Billion 11.80% 0.29x $10.09 Million